Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

BMS team prepares and tests new anti-HIV agents

Feb. 5, 2004

HMG-CoA reductase mediates the anticortisol effect of procaine

Feb. 5, 2004

A-221-HIV to enter clinical trials in Latin America

Feb. 4, 2004

IND filing for new HIV vaccine

Feb. 3, 2004

Novel protease inhibitor SM-322377 active against multidrug-resistant HIV variants

Jan. 30, 2004

Epimmune completes enrollment for phase I/II trial of HIV vaccine candidate

Jan. 23, 2004

Xcyte Therapies and Fresenius enter HIV gene therapy collaboration

Jan. 22, 2004

OyaGen, a new company to develop a novel class of HIV drugs

Jan. 20, 2004

Chiron HIV vaccine enters phase I trial

Jan. 19, 2004

Phase I/II HGTV43 gene construct study commences

Jan. 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....